- Regulatory streamlining - Genomic sequencing - National Biotechnology Initiative Act of 2025
2026 · 1st Quarter (Jan 1 - Mar 31)
ELEMENT BIOSCIENCES
Filed by AVIVA STRATEGIES (FKA MGB CONSULTING).
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 17, 2026
- Income
- $39,000.00
- Expenses
- Not reported
- Registrant
- AVIVA STRATEGIES (FKA MGB CONSULTING)
- Client
- ELEMENT BIOSCIENCES
- Filing UUID
- a8b433b7-87c1-432e-a914-29fea2b5f267
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
- National Security Commission on Emerging Biotechnology
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.